GlassScriptPhysician profile
Austyn Mangini
NPI 1821569260
$3,264.26
in general payments reported to CMS, 2019-2025
16 companies · $323 in 2025
The $323 reported for 2025 was more than what 86% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $559 · 2022: $252 · 2023: $152 · 2024: $1,978 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,307 · Travel and Lodging: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,307.09 |
| Travel and Lodging | $1,145.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,181.90 | 2021-2024 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $274.81 | 2021-2025 | Fintepla, Nayzilam, Briviact |
| Jazz Pharmaceuticals INC. | $221.01 | 2022-2024 | |
| Aquestive Therapeutics, INC. | $128.49 | 2022 | |
| Genzyme Corporation | $71.22 | 2023-2024 | |
| Neurelis, INC. | $70.73 | 2021-2025 | Valtoco |
| Collegium Pharmaceutical, INC. | $63.58 | 2025 | Jornay Pm |
| Eisai INC. | $50.80 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $33.73 | 2025 | Strensiq |
| Sanofi-Aventis U.S. LLC | $31.50 | 2025 | |
| Immedica Pharma US, INC. | $30.41 | 2023 | |
| Tolmar, INC. | $29.37 | 2025 | Fensolvi |
| Novo Nordisk INC | $21.79 | 2024 | Wegovy |
| Eton Pharmaceuticals, INC. | $19.13 | 2025 | Increlex, Alkindi, Khindivi |
| Abbott Laboratories | $19.04 | 2025 | Freestyle Libre 3 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $16.75 | 2025 | Triptodur |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austyn Mangini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.